Literature DB >> 26276450

Enhanced parathyroid hormone levels are associated with left ventricle hypertrophy in very elderly men and women.

Alexandre A S Soares1, Wladimir M Freitas2, Andre V T Japiassú2, Luiz A Quaglia2, Simone N Santos2, Alexandre C Pereira3, Wilson Nadruz Junior2, Andrei C Sposito4.   

Abstract

Serum parathyroid hormone (PTH) has been found to be associated with cardiovascular mortality in the elderly, but little is known about the mechanisms underlying this association. This study investigated the association between PTH and structural and functional changes of the heart and arterial wall in a cohort of very elderly individuals. Healthy individuals aged 80 years or more (n = 90) underwent evaluation of serum PTH, cardiac morphology and function by Doppler echocardiography, endothelium dependent and independent vasodilatation by brachial reactivity, carotid stiffness and intima-media thickness by ultrasound, and coronary calcification by computed tomography. Participants with PTH levels above the median 5.8 pmol/L had higher left ventricular mass index (P = .02), relative wall thickness (P = .02), left atrial volume index (P = .03), and shorter deceleration time of E mitral wave (P = .04). Serum PTH levels (odds ratio, 1.027; P = .032) and systolic blood pressure (odds ratio, 1.032; P = .008) were independently associated with left ventricular hypertrophy. No difference was found between PTH groups in flow- or nitrate-mediated brachial artery dilatation, coronary artery calcification, intima-media thickness, or arterial stiffness. Elevation of serum PTH in the very elderly is associated with concentric left ventricular hypertrophy, but no association with arterial wall structure or function was found in this study.
Copyright © 2015 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; arteriosclerosis; atherosclerosis; diastolic; heart failure

Mesh:

Year:  2015        PMID: 26276450     DOI: 10.1016/j.jash.2015.06.020

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  5 in total

Review 1.  Mineral metabolism and cardiovascular disease in CKD.

Authors:  Hideki Fujii; Nobuhiko Joki
Journal:  Clin Exp Nephrol       Date:  2017-01-06       Impact factor: 2.801

2.  Association of bone metabolism markers with coronary atherosclerosis and coronary artery disease in postmenopausal women.

Authors:  Yan Ling; Zhen Wang; Bingjie Wu; Xin Gao
Journal:  J Bone Miner Metab       Date:  2017-06-22       Impact factor: 2.626

Review 3.  Serum biomarkers for arterial calcification in humans: A systematic review.

Authors:  Nienke M S Golüke; Marit A Schoffelmeer; Annemarieke De Jonghe; Mariëlle H Emmelot-Vonk; Pim A De Jong; Huiberdina L Koek
Journal:  Bone Rep       Date:  2022-06-18

4.  Parathyroid hormone and risk of heart failure in the general population: A meta-analysis of prospective studies.

Authors:  Fanbo Meng; Wei Wang; Jianghong Ma; Baisong Lin
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

5.  Impact of parathyroidectomy on left ventricular function in end stage renal disease patients.

Authors:  Shaohua Chen; Kaixiang Sheng; Ying Shen; Hua Jiang; Xin Lei; Lihui Qu; Chunping Xu; Jianghua Chen; Ping Zhang
Journal:  BMC Nephrol       Date:  2020-11-13       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.